Fatty liver disease determines the progression of coronary artery calcification in a metabolically healthy obese population

被引:8
作者
Kang, Yu Mi [1 ]
Jung, Chang Hee [1 ]
Cho, Yun Kyung [1 ]
Lee, Seung Eun [1 ]
Lee, Min Jung [2 ]
Hwang, Jenie Yoonoo [2 ]
Kim, Eun Hee [2 ]
Park, Joong-Yeol [1 ]
Lee, Woo Je [1 ]
Kim, Hong-Kyu [2 ]
机构
[1] Univ Ulsan, Coll Med, Dept Internal Med, Asan Med Ctr, Seoul, South Korea
[2] Univ Ulsan, Coll Med, Dept Hlth Screening & Promot Ctr, Asan Med Ctr, Seoul, South Korea
来源
PLOS ONE | 2017年 / 12卷 / 04期
关键词
CARDIOVASCULAR-DISEASE; ALL-CAUSE; RISK; ASSOCIATION; CALCIUM; ATHEROSCLEROSIS; FRAMINGHAM; MORTALITY; DEFINITION; PREDICTION;
D O I
10.1371/journal.pone.0175762
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Objectives Metabolically healthy obese (MHO) phenotype describes an obese state with a favorable metabolic profile. However, the prognosis of this subpopulation remains controversial. We aimed to examine whether MHO phenotype is associated with progression of atherosclerotic activity, reflected as the changes in coronary artery calcification (CAC) over time. If so, we sought to determine the role of fatty liver disease (FLD), the hallmark of hepatic steatosis, in this progression. Methods We enrolled 1,240 asymptomatic subjects who underwent repeated CAC score measurement during routine health examinations. CAC score progression was defined as either incident CAC in a population free of CAC at baseline, or an increase by >= 2.5 units between the baseline and final square root of CAC scores in participants with detectable CAC at baseline. Subjects were stratified by body mass index (cut-off, 25.0 kg/m(2)) and metabolic health state using Adult Treatment Panel-III criteria. FLD was assessed via ultrasonography. Results Over 2.9 years of follow-up, 25.2% of total subjects exhibited CAC score progression. The MHO phenotype was not significantly associated with CAC score progression (multivariate adjusted-odds ratio [OR], 1.45; 95% confidence interval [CI], 0.93-2.25), as compared to the metabolically healthy non-obese (MHNO) phenotype. However, subgroup analysis indicated that the MHO/FLD phenotype was significantly associated with CAC score progression (multivariate adjusted-OR, 2.37; 95% CI, 1.34-4.16), as compared to the MHNO/no FLD phenotype, whereas the MHO/no FLD phenotype was not (multivariate adjusted OR, 1.25; 95% CI, 0.71-2.24). Conclusions Obese individuals with FLD have an increased risk of atherosclerosis progression, despite their healthy metabolic profile. Preventive interventions targeting cardiometabolic risk factors should be considered in such individuals, regardless of the weight status.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Influence of the definition of "metabolically healthy obesity" on the progression of coronary artery calcification
    Yoon, Ji Won
    Jung, Chan-Hyeon
    Kim, Min-Kyung
    Park, Hyo Eun
    Park, Kyong Soo
    Jang, Hak Chul
    Moon, Min Kyong
    Choi, Su-Yeon
    Koo, Bo Kyung
    PLOS ONE, 2017, 12 (06):
  • [2] Relationship between metabolically healthy obesity and coronary artery calcification
    Seo, Yoo-Bin
    Kang, Sung-Goo
    Song, Sang-Wook
    OBESITY RESEARCH & CLINICAL PRACTICE, 2024, 18 (01) : 28 - 34
  • [3] Nonalcoholic Fatty Liver Disease and Coronary Artery Calcification
    Stefan, Norbert
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2016, 14 (09) : 1345 - 1346
  • [4] Coronary artery disease risk among obese metabolically healthy young men
    Twig, Gilad
    Gerstein, Hertzel C.
    Shor, Dana Ben-Ami
    Derazne, Estela
    Tzur, Dorit
    Afek, Arnon
    Tirosh, Amir
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2015, 173 (03) : 305 - 312
  • [5] Coronary Artery Calcification Score and the Progression of Chronic Kidney Disease
    Yun, Hae-Ryong
    Joo, Young Su
    Kim, Hyung Woo
    Park, Jung Tak
    Chang, Tae Ik
    Son, Nak-Hoon
    Yoo, Tae-Hyun
    Kang, Shin-Wook
    Sung, Suah
    Lee, Kyu-Beck
    Lee, Joongyub
    Oh, Kook-Hwan
    Han, Seung Hyeok
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (08): : 1590 - 1601
  • [6] Less liver fibrosis in metabolically healthy compared with metabolically unhealthy obese patients with non-alcoholic fatty liver disease
    Gutierrez-Grobe, Y.
    Juarez-Hernandez, E.
    Sanchez-Jimenez, B. A.
    Uribe-Ramos, M. H.
    Ramos-Ostos, M. H.
    Uribe, M.
    Chavez-Tapia, N. C.
    DIABETES & METABOLISM, 2017, 43 (04) : 332 - 337
  • [7] Nonalcoholic Fatty Liver Disease and Coronary Artery Calcification in a Northern Chinese Population: a Cross Sectional Study
    Wu, Rina
    Hou, Feng
    Wang, Xiaomin
    Zhou, Yong
    Sun, Kai
    Wang, Youxin
    Liu, Henghui
    Wu, Jing
    Zhao, Ruiping
    Hu, Jiang
    SCIENTIFIC REPORTS, 2017, 7
  • [8] Physical activity and the progression of coronary artery calcification
    Sung, Ki-Chul
    Hong, Yun Soo
    Lee, Jong-Young
    Lee, Seung-Jae
    Chang, Yoosoo
    Ryu, Seungho
    Zhao, Di
    Cho, Juhee
    Guallar, Eliseo
    Lima, Joao A. C.
    HEART, 2021, 107 (21) : 1710 - 1716
  • [9] Relationship of epicardial fat thickness and nonalcoholic fatty liver disease to coronary artery calcification: From the CAESAR study
    Kim, Byung Jin
    Cheong, Eun Sun
    Kang, Jung Gyu
    Kim, Bum Soo
    Kang, Jin Ho
    JOURNAL OF CLINICAL LIPIDOLOGY, 2016, 10 (03) : 619 - 626
  • [10] Non-alcoholic fatty liver disease is a strong predictor of coronary artery calcification in metabolically healthy subjects: A cross-sectional, population-based study in middle-aged subjects
    Gummesson, Anders
    Stromberg, Ulf
    Schmidt, Caroline
    Kullberg, Joel
    Angeras, Oskar
    Lindgren, Stefan
    Hjelmgren, Ola
    Toren, Kjell
    Rosengren, Annika
    Fagerberg, Bjorn
    Brandberg, John
    Bergstrom, Goran
    PLOS ONE, 2018, 13 (08):